Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
210M
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
99.8M
-
Shares change
-
-506K
-
Total reported value, excl. options
-
$378M
-
Value change
-
-$88.3M
-
Put/Call ratio
-
0.98
-
Number of buys
-
58
-
Number of sells
-
-55
-
Price
-
$3.79
Significant Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) as of Q2 2019
154 filings reported holding BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share as of Q2 2019.
BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) has 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 99.8M shares
of 210M outstanding shares and own 47.6% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (14.4M shares), JANUS HENDERSON GROUP PLC (9.6M shares), BlackRock Inc. (8.93M shares), MILLENNIUM MANAGEMENT LLC (7.1M shares), VANGUARD GROUP INC (6.69M shares), STATE STREET CORP (6.65M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (6.29M shares), CITADEL ADVISORS LLC (3.49M shares), FMR LLC (2.89M shares), and VHCP Management II, LLC (2.87M shares).
This table shows the top 109 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.